Clasp Therapeutics is a startup based in Finland, 1 tracked investor.
Clasp Therapeutics is a company founded in 2024 headquartered in Finland. Brouky records 1 investor associated with the company.
Clasp Therapeutics develops next-generation precision immuno-oncology T cell engagers targeting cancer-specific mutant protein fragments to selectively destroy tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.